newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics to Participate in Upcoming Investor Conferences

WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated